Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/30/2025

Hypopituitarism Treatment Approach

Diagnostic Evaluation

  • The Endocrine Society recommends morning laboratory tests, including thyroid function, adrenal function, gonadal hormones, and MRI of the sella with pituitary cuts, for comprehensive evaluation of hypopituitarism 1, 3
  • Diagnostic criteria for hypopituitarism include ≥1 pituitary hormone deficiency combined with MRI abnormality, or ≥2 pituitary hormone deficiencies with headache and other symptoms 1, 3

Treatment Algorithm

  • The American College of Endocrinology recommends prioritizing adrenal insufficiency treatment, starting with glucocorticoid replacement, before any other hormone replacement 1, 2, 4
  • Physiologic doses of steroids, typically hydrocortisone 15-25 mg/day in divided doses, should be used for adrenal insufficiency treatment 1, 4
  • The Endocrine Society recommends thyroid hormone replacement, using levothyroxine, only after addressing adrenal insufficiency, and dosing based on free T4 levels, not TSH 1, 4
  • Testosterone replacement for men with hypogonadism and estrogen/progesterone replacement for women with hypogonadism are recommended 1
  • Growth hormone replacement should be considered in patients with documented GH deficiency, particularly in children who have not completed linear growth 5, 6, 7

Special Considerations

  • Radiotherapy-induced hypopituitarism is common, with GH deficiency being universal by 5 years post-radiotherapy, and multiple hormone deficiencies developing in ~20% at 5 years and 80% at 10-15 years post-radiotherapy 6, 8
  • Immune checkpoint inhibitor-induced hypophysitis typically presents with headache and fatigue, and requires lifelong hormone replacement 1
  • Cushing disease in remission requires testing for GH deficiency, monitoring of pubertal progression, and consideration of bone mineral density assessment prior to adult transition 5, 7

Long-Term Monitoring

  • Regular clinical and biochemical monitoring is essential, with lifelong annual clinical assessment for all patients with hypopituitarism 5, 7
  • Monitoring for psychiatric and neurocognitive effects is recommended 7

Common Pitfalls to Avoid

  • Starting thyroid hormone replacement before addressing adrenal insufficiency can precipitate an adrenal crisis 1, 4
  • Relying on TSH levels to monitor central hypothyroidism, instead of using free T4, is not recommended 4
  • Underdiagnosis of GH deficiency, especially in children who have not completed growth, should be avoided 5
  • Hypopituitarism after radiotherapy can develop gradually over years, requiring ongoing surveillance 6